NextGen Healthcare rises as results beat, upbeat forecast

Nextgen Healthcare

17/05/2023 13:50

** Shares of medical technology company NextGen Healthcare
 NXGN.O  rise 2.8% at $17.36 premarket
    ** Q4 revenue & adj profit beat estimates - Refinitiv data
    ** NXGN introduces fiscal 2024 revenue guidance to be in
range of $712 million-$722 million, topping analysts' estimate
of $710.55 million
    ** Co also expects to report fiscal 2024 adj profit in range
of $1.04-$1.11 vs estimates of $1.10
    ** 3 of 9 brokerages rate the stock "Strong buy", 5 "hold"
and 1 "sell"; their median PT is $21.00
    ** Up to last close, stock had fallen 10.06% YTD

 (Reporting by Ashwini Raj in Bengaluru)
 ((Ashwini.Raj@thomsonreuters.com))